New research shows how the drugs can be used to treat ADHD: Study
A new study published in the American Journal of Psychiatry finds that a new class of drugs called cathodal rituximab (Crampton) and its derivative clomipramine (Lumetra) can treat ADHD in patients with moderate to severe symptoms.
“In our studies, we found that these drugs reduce symptoms in adults with ADHD in a variety of ways,” says Dr. Joseph L. Fisch, MD, a clinical psychologist at Yale University School of Medicine.
“The results suggest that these medications could be useful in the treatment of people with ADHD.”
Fisch is lead author of a study published online last week in the Journal of ADHD & ADD.
The study involved 2,824 adults who reported moderate to high ADHD symptoms.
Participants were divided into two groups: one group received placebo, a low dose of clomid and one group got Crampton.
They were then tested twice a week on a computerized device called a self-report questionnaire.
Results showed that the group receiving Cramton significantly reduced their ADHD symptoms, compared to the placebo group.
“It is really striking,” Dr. Fich says.
“When you take these drugs, it’s really hard to understand what’s happening to them.”
Dr Fisch says the study suggests that the drugs could be a way to treat people with moderate-to-severe symptoms of ADHD.
“We are very excited to see if we can take this study and apply it to people who have ADHD,” he says.
The next step, Dr. Frank says, is to do a trial in adults and children to see whether the drugs improve their symptoms.
That would allow the scientists to compare them to people with similar symptoms who receive a placebo.
For more on ADHD and drug development, visit the news center.
A few other things you might want to know about Cramptons treatment: Clomiprimide (Clomid) is a prescription drug that works by slowing the flow of dopamine from the brain to the muscles and to the rest of the body.
It is used to help people with attention deficit disorder and schizophrenia, and is currently used to control seizures in people with Parkinson’s disease and multiple sclerosis.
Its most common use is for people with narcolepsy, a sleep disorder.
Cramptyrex (Clumetrix) is an antidepressant that can be given for anxiety and depression and to treat anxiety, insomnia and attention deficit hyperactivity disorder.
Its only approved for the treatment or prevention of depression.
Its side effects are mild and the drugs do not have long-term side effects.
The drugs can also be used for patients with asthma and migraine headaches.
The drug also helps treat the common cold and seasonal allergies.
Other drugs are being studied to treat chronic pain, insomnia, and mood disorders.
Crapulenide (Crimera) is the first FDA-approved anti-epileptic drug approved in the United States, and it works by targeting the brain and spinal cord.
The medication is being studied in patients who have Crohn’s disease, multiple sclerosis, and Alzheimer’s disease.
Other studies are looking at Cramplux (Clinarix), a nasal spray used to alleviate inflammation, and Ritalin (Ritalin), a stimulant.
“This drug is a very important development because it’s a really important new treatment option for people who are experiencing ADHD,” says Frank.
“You could also use it to treat other symptoms as well, such as panic attacks, sleep disorders, and migraines.”
More from CNN Health on ADHD & amp; ADD: What to know: Is there a cure for ADHD?
ADHD and the ADHD/ADD connection Read more about Crapulin’s treatment.
The findings suggest that Cram Plux could also be effective for treating the common flu.
The research is based on data collected from two trials in children and adults, and more studies are needed to determine if Cramplin and Cramlax are effective in people who do not respond to other medications, says Dr Fich.
“Cramplox could potentially be a very effective treatment option,” he adds.